OS Therapies Ownership | Who Owns OS Therapies?


OverviewForecastFinancialsChart

OS Therapies Ownership Summary


OS Therapies is owned by 4.89% institutional investors, 29.40% insiders, and 65.71% retail investors. Vanguard group is the largest institutional shareholder, holding 1.69% of OSTX shares.

OSTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOS Therapies4.89%29.40%65.71%
SectorHealthcare Stocks 42.64%10.86%46.50%
IndustryBiotech Stocks 45.45%10.77%43.78%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group540.42K1.69%$756.59K
Cm management400.00K1.25%$560.00K
Geode capital management246.04K0.77%$344.45K
Blackrock funding, inc. /de61.42K0.19%$86.00K
Jane street group27.74K0.09%$38.84K
Ubs group18.16K0.06%$25.42K
Stifel financial15.00K0.05%$21.00K
Stratos wealth advisors13.82K0.04%$19.34K
Lpl financial10.11K0.03%$14.16K
Morgan stanley1.00K0.00%$1.40K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management400.00K0.47%$560.00K
Stratos wealth advisors13.82K0.00%$19.34K
Jane street group27.74K-$38.84K
Ground swell capital---
Northwestern mutual wealth management25.00-$35.00
Armstrong advisory group100.00-$140.00
Jpmorgan chase---
Lpl financial10.11K-$14.16K
Ubs group18.16K-$25.42K
Stifel financial15.00K-$21.00K

Top Buyers

HolderShares% AssetsChange
Vanguard group540.42K-352.16K
Geode capital management246.04K-58.35K
Jane street group27.74K-27.74K
Ubs group18.16K-17.93K
Stratos wealth advisors13.82K0.00%13.82K

Top Sellers

HolderShares% AssetsChange
Ground swell capital---20.46K
Sanders morris harris---12.00K
Jpmorgan chase---13.00
Cm management400.00K0.47%-
Armstrong advisory group100.00--

New Positions

HolderShares% AssetsChangeValue
Jane street group27.74K-27.74K$38.84K
Stratos wealth advisors13.82K0.00%13.82K$19.34K
Lpl financial10.11K-10.11K$14.16K
Northwestern mutual wealth management25.00-25.00$35.00

Sold Out

HolderChange
Jpmorgan chase-13.00
Sanders morris harris-12.00K
Ground swell capital-20.46K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252592.31%1,563,221158.93%484.65%18100.00%2100.00%
Jun 30, 202513116.67%603,72755.09%271.63%9125.00%1-
Mar 31, 2025620.00%389,286168.47%1379.49%433.33%1-
Dec 31, 20245-28.57%145,004-9.40%-68.56%3-57.14%1-
Sep 30, 20247-160,043-1-7---

Recent Insider Transactions


DateNameRoleActivityValue
May 07, 2025Auerbach Shalom-Sell$163.92K
Apr 09, 2025Auerbach Shalom-Sell$67.67K
Apr 10, 2025Auerbach Shalom-Sell$13.90K
Feb 14, 2025Auerbach Shalom-Sell$284.30K
Jan 15, 2025Auerbach Shalom-Sell$112.61K

Insider Transactions Trends


DateBuySell
2025 Q2-3
2025 Q1-2
2024 Q4--
2024 Q3--
2003 Q2--

OSTX Ownership FAQ


Who Owns OS Therapies?

OS Therapies shareholders are primarily institutional investors at 4.89%, followed by 29.40% insiders and 65.71% retail investors. The average institutional ownership in OS Therapies's industry, Biotech Stocks , is 45.45%, which OS Therapies falls below.

Who owns the most shares of OS Therapies?

OS Therapies’s largest shareholders are Vanguard group (540.42K shares, 1.69%), Cm management (400K shares, 1.25%), and Geode capital management (246.04K shares, 0.77%). Together, they hold 3.71% of OS Therapies’s total shares outstanding.

Does Blackrock own OS Therapies?

BlackRock is not among the top 10 institutional shareholders of OS Therapies.

Who is OS Therapies’s biggest shareholder by percentage of total assets invested?

Cm management is OS Therapies’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 400K OS Therapies shares, valued at 560K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools